Design of Insulin Variants for Improved Treatment of Diabetes - Peptide and Protein Design for Biopharmaceutical Applications - page 281

[130] A. M. Hennige, R. Lehmann, C. Weigert, K. Moeschel, M. Schauble, E. Metzinger,
R. Lammers and H. U. Haring, Insulin glulisine: Insulin receptor signaling
characteristics in vivo, Diabetes , 54, 361-366 (2005).
[131] J. Halstrøm, U. Ribel, K. Kovacs, L. Sch¨ ffer and A. R. Sørensen, Glycation at B1
makes insulin fast acting, Diabetologia , 34 Suppl. 1, A193, abstract 745 (1991).
[132] M. Baudys, T. Uchio, D. Mix, D. Wilson and S. W. Kim, Physical stabilization of
insulin by glycosylation, J. Pharm. Sci ., 84, 28-33 (1995).
[133] K. M. Stewart, M. F. Wilson and J. M. Rider, Insulin Delivery Devices, J. Pharm.
Pract ., 17, 20-28 (2004).
[134] C. Poulsen, L. Langkjaer and G. Worsoe, Precipitation of insulin aspart and insulin
glulisine products used for continuous subcutaneous insulin infusion, Diab. Tech.
Ther ., 9, 26-35 (2007).
[135] M. Brownlee and A. Cerami, Glycosylated insulin complexed to concanavalin A.
Biochemical basis for a closed-loop insulin delivery system, Diabetes , 32, 499-504
(1983).
[136] I. Hisamitsu, K. Kataoka, T. Okano and Y. Sakurai, Glucose-responsive gel from
phenylborate polymer and poly(vinyl alcohol) - Prompt response at physiological
pH through the interaction of borate with amine group in the gel, Pharm. Res ., 14,
289-293 (1997).
[137] S. W. Kim, C. M. Pai, K. Makino, L. A. Seminoff, D. L. Holmberg, J. M. Gleeson,
D. E. Wilson and E. J. Mack, Self-regulated glycosylated insulin delivery, J. Control.
Rel ., 11, 193-201 (1990).
[138] A. Matsumoto, S. Ikeda, A. Harada and K. Kataoka, Glucose-responsive polymer
bearing a novel phenylborate derivative as a glucose-sensing moiety operating at
physiological pH conditions, Biomacromol ., 4, 1410-1416 (2003).
[139] D. Shiino, K. Kataoka, Y. Koyama, M. Yokoyama, T. Okano and Y. Sakurai,
Controlled-release of insulin from boronic acid gel under physiological conditions,
J. Control. Rel ., 28, 317-318 (1994).
[140] D. Shiino, Y. Murata, K. Kataoka, Y. Koyama, M. Yokoyama, T. Okano and
Y. Sakurai, Preparation and characterization of a glucose-responsive insulin-releas-
ing polymer device, Biomaterials , 15, 121-128 (1994).
[141] D. Shiino, Y. Murata, A. Kubo, Y. J. Kim, K. Kataoka, Y. Koyama, A. Kikuchi,
M. Yokoyama, Y. Sakurai and T. Okano, Amine-containing phenylboronic acid gel
for glucose-responsive insulin release under physiological pH, J. Control. Rel ., 37,
269-276 (1995).
[142] P. J. Stout, J. R. Racchini, M. E. Hilgers and S. E. Noujaim, Continuous glucose
monitoring: Key challenges to replacing episodic SMBG, Diab. Res. Clin. Pract ., 74,
S97-S100 (2006).
[143] T. Hoeg-Jensen, S. Havelund, P. K. Nielsen and J. Markussen, Reversible insulin
self-assembly under carbohydrate control, J. Am. Chem. Soc ., 127, 6158-6159
(2005).
[144] C. M. Peterson, L. B. Jovanovic and M. Brownlee, Closing the loop: Practical and
theoretical, Diabetes Care , 3, 318-321 (1980).
[145] E. Renard, G. Costalat, H. Chevassus and J. Bringer, Artificial beta-cell: Clinical
experience toward an implantable closed-loop insulin delivery system, Diab.
Metab ., 32, 497-502 (2006).
[146] E. S. Wilkins, Towards implantable glucose sensors: a review, J. Biomed. Eng ., 11,
354-361 (1989).